Effects of a Blueberry Enriched Diet on the Skeletal Muscle Regenerative Process
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04262258 |
Recruitment Status :
Completed
First Posted : February 10, 2020
Last Update Posted : February 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Skeletal Muscle Disorder | Dietary Supplement: Blueberry enriched diet | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 22 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Basic Science |
Official Title: | Effect of a Blueberry Enriched Diet on Skeletal Muscle Progenitor Cells |
Actual Study Start Date : | September 29, 2017 |
Actual Primary Completion Date : | December 31, 2019 |
Actual Study Completion Date : | December 31, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Blueberry Enriched Diet
The blueberry intervention will consist of participants ingesting two servings of 19 g freeze dried blueberry powder (equivalent to 250 g whole blueberries) daily for six weeks. Subjects will ingest the freeze dried blueberries orally. Freeze dried blueberry powder will be mixed with 8-10 ounces of water and consumed. Subjects will be asked to rinse the cup to wash any remaining blueberries off of the cup and consume the rinse water. Subjects will be given a two week supply at baseline (week 0) and a four week supply when they return for their blood draw at week 2. Subjects will be asked to return empty packets and check-off daily records as a measure of compliance.
|
Dietary Supplement: Blueberry enriched diet
The blueberry intervention will consist of participants ingesting two servings of 19 g freeze dried blueberry powder (equivalent to 250 g whole blueberries) daily for six weeks. Subjects will ingest the freeze dried blueberries orally. Freeze dried blueberry powder will be mixed with 8-10 ounces of water and consumed. Subjects will be asked to rinse the cup to wash any remaining blueberries off of the cup and consume the rinse water. Subjects will be given a two week supply at baseline (week 0) and a four week supply when they return for their blood draw at week 2. Subjects will be asked to return empty packets and check-off daily records as a measure of compliance.
Other Name: freeze dried blueberries |
- Change in number of muscle progenitor cells on the imaging hemocytometer from baseline to 6 weeks of blueberry enriched diet [ Time Frame: serum is obtained over the course of 6 weeks. Cell number is tracked over 12 days. ]Serum obtained from women consuming the blueberry enriched diet will be pooled. Cultured muscle progenitor cells (in vitro) from young and old women (obtained from a previous study) will be treated with serum from women consuming the blueberry enriched diet. The number of cells counted will be used as a marker of cell proliferation. Cell number will be measured using a hemocytometer.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 79 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Young 21-40 y women
- old 65-79 y women
Exclusion Criteria:
- known musculoskeletal disease (e.g., rheumatoid arthritis)
- movement disorder (e.g., Parkinson's disease) or other disorder that might affect skeletal muscle mass, function, or metabolism (e.g. diabetes, cancer)
- obese (BMI ≥ 30.0 kg/m2)
- long-term treatment with exogenous hormones or other pharmacological interventions -known to or that have the potential to influence muscle mass or function (e.g. glucocorticoids)
- antibiotic use within 6 months of intervention

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04262258
United States, New York | |
Human Metabolic Research Unit | |
Ithaca, New York, United States, 14853 |
Responsible Party: | Anna Thalacker-Mercer, Assistant Professor, Cornell University |
ClinicalTrials.gov Identifier: | NCT04262258 |
Other Study ID Numbers: |
82422 |
First Posted: | February 10, 2020 Key Record Dates |
Last Update Posted: | February 11, 2020 |
Last Verified: | February 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Muscular Diseases Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases |